Oncology & Cancer

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 clinical variants covering ...

Diseases, Conditions, Syndromes

AUA: Most women report dysfunctional toileting behaviors

(HealthDay)—Many women report dysfunctional toileting behaviors, which are associated with lower urinary tract symptoms, according to a study presented at the annual meeting of the American Urological Association, held ...

Diseases, Conditions, Syndromes

CV autonomic neuropathy predicts urological issues

(HealthDay)—For men with type 1 diabetes, cardiovascular autonomic neuropathy is associated with erectile dysfunction and/or lower urinary tract symptoms, according to a study published in the June issue of The Journal ...

Diseases, Conditions, Syndromes

Correcting metabolic abnormalities may help lessen urinary problems

Metabolic syndrome is linked with an increased frequency and severity of lower urinary tract symptoms, but weight loss surgery may lessen these symptoms. The findings, which come from two studies published in BJU International, ...

Diseases, Conditions, Syndromes

Testosterone therapy doesn't worsen urinary symptoms

(HealthDay)—For hypogonadal men, testosterone replacement therapy is associated with a low risk of worsening lower urinary tract symptoms, according to a study published in the November issue of The Journal of Urology.

Oncology & Cancer

Men's bladder problems may herald heart disease, diabetes

Men who regularly get up more than once a night to pee could be suffering from a range of health conditions, many of which can be treated if GPs look for them, according to University of Adelaide researchers.

Diseases, Conditions, Syndromes

High doses of saw palmetto appear safe over 18 months

(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

Oncology & Cancer

High doses of saw palmetto don't impact serum PSA

(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research published in ...

page 2 from 4